Pathophysiological role of nuclear receptor signalling
Team Leader : Daniel METZGER
Department : Functional genomics and cancer
The active form of the hormone vitamin D controls calcium and phosphate levels in the body. In addition, it contributes to the regulation of the inflammation and cell proliferation, conferring a protective, even therapeutic, role in various cancers and autoimmune diseases.
To date, the mechanisms underlying the activities of vitamin D have not been elucidated. This lack of understanding limits its clinical use, since the doses required for the treatment of cancers or autoimmune diseases induce hypercalcemia; resulting in calcification of the kidneys, heart and vessels, leading to dysfunction of these organs.
Our group is interested in understanding how vitamin D controls calcium homeostasis and tumor progression. We focus on rare diseases characterized by impaired vitamin D signaling, and on prostate cancer.
We use patient cells and mouse models recapitulating human pathologies, and leverage single-cell and spatial transcriptomic analyses coupled with functional validations.
We also collaborate with chemists to characterise new vitamin D analogues with potent therapeutic activities for many diseases that are refractory to current treatments.
On April 3, the research teams led by Drs Daniel Metzger and Gilles Laverny received a cheque for €10,000 to further their work on prostate cancer.
Read more
Gilles Laverny
Individual fellowship - Inserm (2021)
Poster prize - Fondation Maladies Rares (2019)
Trainee Award - Vitamin D workshop (2015)
Daniela Rovito
Young researcher award - OSCAR (2021)
Kateryna Len-Tayon
Trainee Award - Vitamin D workshop (2024).
Jury award - Fondation ARC (2024).
Poster prize - Association pour la Recherche sur les Tumeurs Prostatiques (2021)
PhD fellowship - Ministère de l'Education Nationale, de l'Enseignement supérieur et de la Recherche (2020)
Noe Pierrat
PhD fellowship - Fondation pour la Recherche Médicale (2023)
Vanessa Friedrich
PhD fellowship Inserm/Pfizer (2024)
Frontiers in Immunology ; Volume: 9 ; Page: 536
Oncogene ; Volume: 36 ; Page: 6420-6431
Acta Neuropathologica ; Volume: 134 ; Page: 655-666
Journal of Experimental Medicine ; Volume: 214 ; Page: 1581-1592
Frontiers in Physiology ; Volume: 8
Cell Reports ; Volume: 10 ; Page: 516-526
European Journal of Vascular and Endovascular Surgery ; Volume: 49 ; Page: 205-212
Nature Communications ; Volume: 6 ; Page: 10210
Toxicology Letters ; Volume: 217 ; Page: 91-101
Page 3 of 3
Team Leader : Daniel METZGER
Department : Functional genomics and cancer